Abilify Solution For Injection 9.75Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Abilify: Solution for injection (9.75mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

ARIPIPRAZOLE (ay ri PIP ray zole) is an atypical antipsychotic. It is used to treat agitation associated with schizophrenia or bipolar disorder, also known as manic-depression.

In-Depth Information

Abilify 9.75mg/1.3ml Solution for Injection

NDC: 591480016
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Mania, Schizophrenia, Bipolar Disorder

Storage Information
Store in original package until time of use
Protect from light
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Abilify 9.75mg/1.3ml Solution for Injection

Reported Side Effects for Abilify 9.75mg/1.3ml Solution for Injection

High Prolactin Level Incidence:
<0.1%*
Severity: MODERATE
Onset: DELAYED
Gynecomastia Incidence:
<0.1%*
Severity: MILD
Onset: DELAYED
Double Vision Incidence:
<0.1%*
Severity: MILD
Onset: EARLY
Inability To Sleep Incidence:
<18.0%*
Severity: MILD
Onset: EARLY
Breast Pain Incidence:
<0.1%*
Severity: MILD
Onset: DELAYED
Convulsions Incidence:
<0.2%*
Severity: SEVERE
Onset: DELAYED
Low Platelet Count Incidence:
<0.1%*
Severity: MODERATE
Onset: DELAYED
Breakdown Of Muscle Incidence:
<0.1%*
Severity: SEVERE
Onset: DELAYED
Long Qt Syndrome Incidence:
<0.1%*
Severity: MODERATE
Onset: RAPID
Hives Incidence:
<0.1%*
Severity: MILD
Onset: RAPID
Heart Attack Incidence:
<0.1%*
Severity: SEVERE
Onset: DELAYED
Liver Infection Incidence:
<0.1%*
Severity: MODERATE
Onset: DELAYED
Increased Blood Sugar Incidence:
<17.6%*
Severity: MODERATE
Onset: DELAYED
Yellow Skin Incidence:
<0.1%*
Severity: MODERATE
Onset: DELAYED
Irregular Periods Incidence:
<0.1%*
Severity: MILD
Onset: DELAYED
No Menstrual Periods Incidence:
<0.1%*
Severity: MILD
Onset: DELAYED
Chest Pain Incidence:
<0.1%*
Severity: MODERATE
Onset: EARLY
Sleep-related Behaviors Incidence:
<0.1%*
Severity: MODERATE
Onset: EARLY
Sleep-Walking Incidence:
<0.1%*
Severity: MILD
Onset: EARLY
Irregular Heart Beat Incidence:
<0.1%*
Severity: SEVERE
Onset: EARLY
Irregular Heart Rate Incidence:
<0.1%*
Severity: SEVERE
Onset: EARLY
Heart Block Incidence:
<0.1%*
Severity: SEVERE
Onset: EARLY
Skin Rash Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Suddenly Stopped Heart Incidence:
<0.1%*
Severity: SEVERE
Onset: EARLY
Priapism Incidence:
<0.1%*
Severity: MODERATE
Onset: EARLY
Orgasm Dysfunction Incidence:
<0.1%*
Severity: MILD
Onset: DELAYED
High Body Temperature Incidence:
<0.1%*
Severity: MODERATE
Onset: DELAYED
High Bilirubin Level Incidence:
<0.1%*
Severity: MODERATE
Onset: DELAYED
Increased Sexual Desire Incidence:
<0.1%*
Severity: MILD
Onset: DELAYED
Headache Incidence:
<27.0%*
Severity: MILD
Onset: EARLY
Decreased Memory Incidence:
0.1-0.9%*
Severity: MODERATE
Onset: DELAYED
Heartburn Incidence:
0.1-0.9%*
Severity: MILD
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
0.1-0.9%*
Severity: MODERATE
Onset: DELAYED
Impotence (erectile Dysfunction) Incidence:
0.1-0.9%*
Severity: MODERATE
Onset: DELAYED
Decreased Sexual Desire Incidence:
0.1-0.9%*
Severity: MILD
Onset: DELAYED
Fluid Retention Incidence:
0.1-0.9%*
Severity: MODERATE
Onset: DELAYED
Chest Pain Incidence:
0.1-0.9%*
Severity: MODERATE
Onset: EARLY
Muscle Weakness Incidence:
0.1-0.9%*
Severity: MODERATE
Onset: DELAYED
Photosensitivity Incidence:
0.1-0.9%*
Severity: MILD
Onset: DELAYED
Rapid Heart Rate Incidence:
0.1-0.9%*
Severity: MODERATE
Onset: EARLY
Rapid Muscle Twitches Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: DELAYED
Nighttime Urination Incidence:
0.1-0.9%*
Severity: MILD
Onset: EARLY
Low Potassium Levels Incidence:
0.1-0.9%*
Severity: MODERATE
Onset: DELAYED
Slow Heart Beat Incidence:
0.1-0.9%*
Severity: SEVERE
Onset: RAPID
Low Blood Sodium Levels Incidence:
0.1-0.9%*
Severity: MODERATE
Onset: DELAYED
Low Blood Pressure Incidence:
0.1-0.9%*
Severity: MODERATE
Onset: RAPID
Low Blood Sugar Incidence:
0.1-0.9%*
Severity: MODERATE
Onset: EARLY
High Blood Pressure Incidence:
0.1-0.9%*
Severity: MODERATE
Onset: EARLY
Excessive Sweating Incidence:
0.1-0.9%*
Severity: MILD
Onset: DELAYED
Hirsutism Incidence:
0.1-0.9%*
Severity: MILD
Onset: DELAYED
Stuffy Nose Incidence:
0.1-0.9%*
Severity: MILD
Onset: EARLY
Delirium Incidence:
0.1-0.9%*
Severity: MODERATE
Onset: EARLY
Light Sensitivity Incidence:
0.1-0.9%*
Severity: MODERATE
Onset: EARLY
Itching Incidence:
0.1-0.9%*
Severity: MILD
Onset: RAPID
Shortness Of Breath Incidence:
0.1-0.9%*
Severity: MODERATE
Onset: EARLY
Retaining Urine Incidence:
0.1-0.9%*
Severity: MODERATE
Onset: EARLY
Hair Loss Incidence:
0.1-0.9%*
Severity: MILD
Onset: DELAYED
Postural Low Blood Pressure Incidence:
0.2-1.0%*
Severity: MODERATE
Onset: DELAYED
Fainting Incidence:
0.2-0.5%*
Severity: MILD
Onset: EARLY
Injection Site Reaction Incidence:
>1.0%*
Severity: MILD
Onset: RAPID
Muscle And/Or Bone Pain Incidence:
1.0-4.0%*
Severity: MILD
Onset: EARLY
Restlessness Incidence:
1.0-6.0%*
Severity: MILD
Onset: EARLY
Weakness Incidence:
>1.0%*
Severity: MILD
Onset: DELAYED
Joint Pain Incidence:
1.0-4.0%*
Severity: MILD
Onset: DELAYED
Weight Loss Incidence:
>1.0%*
Severity: MILD
Onset: DELAYED
Uncontrolled Urination Incidence:
>1.0%*
Severity: MODERATE
Onset: EARLY
Decreased Appetite Incidence:
>1.0%*
Severity: MILD
Onset: DELAYED
Muscle Pain Incidence:
2.0%*
Severity: MILD
Onset: EARLY
Rapid Heart Rate Incidence:
2.0%*
Severity: MODERATE
Onset: RAPID
Constipation Incidence:
2.0-11.0%*
Severity: MODERATE
Onset: DELAYED
Irritability Incidence:
2.0%*
Severity: MILD
Onset: DELAYED
Tired Incidence:
2.0-17.0%*
Severity: MILD
Onset: EARLY
Nose Bleed Incidence:
2.0%*
Severity: MILD
Onset: DELAYED
Weight Gain Incidence:
2.2-26.3%*
Severity: MILD
Onset: DELAYED
Cough Incidence:
3.0%*
Severity: MILD
Onset: DELAYED
Drowsiness Incidence:
3.0-23.0%*
Severity: MILD
Onset: EARLY
Tiredness Incidence:
3.0-5.0%*
Severity: MILD
Onset: EARLY
Lightheadedness Incidence:
3.0-10.0%*
Severity: MILD
Onset: EARLY
Blurred Vision Incidence:
3.0-8.0%*
Severity: MODERATE
Onset: EARLY
Causing To Be Hungry Incidence:
3.0-7.0%*
Severity: MILD
Onset: DELAYED
Vomiting Incidence:
3.0-14.0%*
Severity: MILD
Onset: EARLY
Sore Throat Incidence:
3.0-9.0%*
Severity: MILD
Onset: DELAYED
Stomach Pain Incidence:
3.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
4.0%*
Severity: MILD
Onset: EARLY
Tooth Pain Incidence:
4.0%*
Severity: MILD
Onset: DELAYED
Fever Incidence:
4.0-9.0%*
Severity: MILD
Onset: EARLY
Extra Saliva Production Incidence:
4.0-6.0%*
Severity: MILD
Onset: EARLY
Fecal Incontinence Incidence:
5.0%*
Severity: MODERATE
Onset: EARLY
Dry Mouth Incidence:
5.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
8.0-15.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
9.0%*
Severity: MILD
Onset: EARLY
Nervousness Incidence:
17.0%*
Severity: MILD
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Abilify 9.75mg/1.3ml Solution for Injection

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Major Lifestyle Interaction
Alcohol and Abilify 9.75mg/1.3ml Solution for Injection(Aripiprazole)
Alcohol and CNS Depressants(Aripiprazole)
Avoid alcohol-containing drinks while taking this medicine. Using this drug along with alcohol can lead to serious side effects. You may feel drowsy or more tired when taking these drugs together. Do not drive or operate machinery until you know how this drug affects you, and especially if you are drinking alcohol-containing beverages. If you notice slurred speech, confusion, severe weakness, or difficulty breathing, contact your health care provider immediately.
Moderate Lifestyle Interaction
Grapefruit juice and Abilify 9.75mg/1.3ml Solution for Injection(Aripiprazole)
Grapefruit juice and Aripiprazole(Aripiprazole)
Tell your health care provider if you drink grapefruit juice regularly. An interaction between Aripiprazole and Grapefruit juice is possible, but they may be used together. Grapefruit juice may change the ammount of Aripiprazole in the blood. If you drink Grapefruit juice regularly, do not change how often or how much grapefruit juice you drink until you talk to your health care provider. If you experience nausea, vomiting, drowsiness, tremor or other unusual effect, contact your health care provider.
Moderate Lifestyle Interaction
Marijuana and Abilify 9.75mg/1.3ml Solution for Injection(Aripiprazole)
Marijuana and Antipsychotics(Aripiprazole)
Marijuana smoke may decrease the effectiveness of Antipsychotics by increasing the elimination of Antipsychotic medications from the body. If you smoke Marijuana, Medical, notify your prescriber if you experience changes in mood (like agitation or hearing or seeing things that are not really there) that may indicate your Antipsychotic medication is not working as well for you. If you suddenly stop smoking Marijuana, Medical, this may increase the actions of Antipsychotics; notify your prescriber if you notice increased drowsiness, dizziness or other unusual side effects.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Abilify

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.